Cargando…

Inhibition of the renin-angiotensin-aldosterone system prevents and cures atrial fibrillation: An overview of systematic reviews

Background: Atrial fibrillation (AF) is a type of arrhythmia that represents a severe health hazard. The current therapies for AF have achieved success in some conditions. However, because the mechanisms underlying the occurrence and development of this disease remain unclear, the current treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Zhixiang, Zhang, Dong, Ji, Qiuhe, Yi, Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104282/ https://www.ncbi.nlm.nih.gov/pubmed/33950930 http://dx.doi.org/10.1097/MD.0000000000025559

Ejemplares similares

Aldosterone and renin in cardiac patients referred for catheterization
por: Erne, Paul, et al.
Publicado: (2017)

Association between renin–angiotensin–aldosterone system blockade and future osteoporotic fracture risk in hypertensive population: A population-based cohort study in Taiwan
por: Chen, Chang-I., et al.
Publicado: (2017)

The effects of ACEI/ARB, aldosterone receptor antagonists and statins on preventing recurrence of atrial fibrillation: A protocol for systematic review and network meta-analysis
por: Jia, Qiulei, et al.
Publicado: (2021)

Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study
por: Hsieh, Yu-Cheng, et al.
Publicado: (2016)

Aldosterone-to-Renin Ratio Is Associated With Reduced 24-Hour Heart Rate Variability and QTc Prolongation in Hypertensive Patients
por: Grübler, Martin R., et al.
Publicado: (2016)

Low Response of Renin–Angiotensin System to Sodium Intake Intervention in Chinese Hypertensive Patients
por: Feng, Weijing, et al.
Publicado: (2016)

Is ablation to atrial fibrillation termination of persistent atrial fibrillation the end point?: A systematic review and meta-analysis
por: Li, Fanghui, et al.
Publicado: (2019)

Polymorphisms of Renin-Angiotensin-Aldosterone System Gene in Chinese Han Patients with Nonfamilial Atrial Fibrillation
por: Zhao, Li-qun, et al.
Publicado: (2015)

Inflammatory markers in paroxysmal atrial fibrillation and the protective role of renin-angiotensin-aldosterone system inhibitors
por: ROŞIANU, ŞTEFAN HORIA, et al.
Publicado: (2013)

Impact of renin–angiotensin–aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension
por: Xu, Wei, et al.
Publicado: (2022)

Ranolazine in the prevention and treatment of atrial fibrillation: A protocol for meta-analysis
por: Yuan, Chengdai, et al.
Publicado: (2021)

Correction: Polymorphisms of Renin-Angiotensin-Aldosterone System Gene in Chinese Han Patients with Nonfamilial Atrial Fibrillation
Publicado: (2015)

Relationship between psychological factors and atrial fibrillation: A meta-analysis and systematic review
por: Fu, Yonghui, et al.
Publicado: (2020)

Atrial fibrillation in heart failure patients: An update on renin–angiotensin–aldosterone system pathway blockade as a therapeutic and prevention target
por: Koniari, Ioanna, et al.
Publicado: (2023)

Effect of Beta Blockers and Renin–Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Lee, Pil Hyung, et al.
Publicado: (2016)

Mitral annular calcification is associated with atrial fibrillation and major cardiac adverse events in atrial fibrillation patients: A systematic review and meta-analysis
por: Li, Yimin, et al.
Publicado: (2019)

Complicated atrial tachycardia due to atrial fibrillation originating from the superior vena cava: A case report
por: Wang, Huan, et al.
Publicado: (2017)

Comparison of the effects of left atrial appendage closure and oral anticoagulants in preventing stroke in patients with non-valvular atrial fibrillation: A protocol for systematic review and meta-analysis
por: Yue, Deyong, et al.
Publicado: (2021)

Indonesian registry on atrial fibrillation (OneAF)
por: Raharjo, Sunu Budhi, et al.
Publicado: (2021)

Paraoxonase 1 and atrial fibrillation: Is there a relationship?
por: Istratoaie, Sabina, et al.
Publicado: (2022)

Usefulness of HATCH score in the prediction of new-onset atrial fibrillation for Asians
por: Suenari, Kazuyoshi, et al.
Publicado: (2017)

Left atrial wall dyskinesia assessed during contractile phase as a predictor of atrial fibrillation recurrence after electrical cardioversion performed due to persistent atrial fibrillation
por: Wałek, Paweł, et al.
Publicado: (2020)

Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation: A real-world experience
por: Gorczyca, Iwona, et al.
Publicado: (2020)

High mobility group box 1 was associated with thrombosis in patients with atrial fibrillation
por: Xu, Qiwen, et al.
Publicado: (2018)

Echocardiographic assessment of left atrial function for prediction of efficacy of catheter ablation for atrial fibrillation
por: Pilichowska-Paszkiet, Ewa, et al.
Publicado: (2021)

Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19
por: Williams, Bryan, et al.
Publicado: (2020)

The Renin-Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition
por: Atlas, Steven A.
Publicado: (2007)

Digoxin Use and Adverse Outcomes in Patients With Atrial Fibrillation
por: Zeng, Wu-Tao, et al.
Publicado: (2016)

Oncostatin M was associated with thrombosis in patients with atrial fibrillation
por: Xie, Jun, et al.
Publicado: (2017)

Influence of hemoglobin concentration on the in-hospital outcomes in newly diagnosed heart failure patients with atrial fibrillation: Finding from CCC-AF (improving care for cardiovascular disease in China-atrial fibrillation) project
por: Dong, Mengya, et al.
Publicado: (2022)

Atrioesophageal fistula after atrial fibrillation catheter ablation: A case report
por: He, Fan, et al.
Publicado: (2021)

Effects of Angiotensin Converting Enzyme Inhibition or Angiotensin Receptor Blockade in Dialysis Patients: A Nationwide Data Survey and Propensity Analysis
por: Wu, Cho-Kai, et al.
Publicado: (2015)

Left atrial deformation and risk of transient ischemic attack and stroke in patients with paroxysmal atrial fibrillation
por: Chen, Jian, et al.
Publicado: (2023)

Early effects of paroxysmal atrial fibrillation on plasma markers of fibrinolysis
por: Negreva, Mariya, et al.
Publicado: (2016)

Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage
por: Wu, Victor Chien-Chia, et al.
Publicado: (2021)

Functional mitral regurgitation: predictor for atrial substrate remodeling and poor ablation outcome in paroxysmal atrial fibrillation
por: Qiao, Yu, et al.
Publicado: (2016)

Prognostic impact of atrial fibrillation in patients with severe acute respiratory syndrome coronavirus 2 infection
por: Lee, Ji Hyun, et al.
Publicado: (2021)

Emergence and evolution of the renin–angiotensin–aldosterone system
por: Fournier, David, et al.
Publicado: (2012)

Beyond the Circulating Renin–Angiotensin Aldosterone System
por: De Mello, Walmor C.
Publicado: (2014)

The renin‐angiotensin‐aldosterone system and its suppression
por: Ames, Marisa K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fus3hpupqs0ttig6nv384vlmnc